Exchanges & Data · NYSE: MSCI
MSCI earnings: results, call transcripts & KPI history
2 quarters · fiscal year ends December · next results expected around 27 Jan 2027
Latest: Q3 2026
MSCI posted best-ever recurring net-new sales in Analytics and Private Capital Solutions as AI-built products win hedge funds, asset owners and newer client segments.
MSCI had its best-ever quarter for recurring net-new sales in Analytics and Private Capital Solutions, and its best Q3 in Index. Demand came from asset owners, hedge funds and Asia-Pacific. The largest deal turned MSCI from a vendor into a portfolio analytics partner for a major Asian sovereign wealth fund. New products contributed over 50% more to sales than a year ago. MSCI also formalized its UBS private-assets agreement and closed the First Street climate-risk acquisition, while sustainability stayed weak.
Quarters
KPI history
Fourth quarter worked out from the annual figure.
Data
| Q4 2024 | $743.5M * |
| Q1 2025 | $745.8M |
| Q2 2025 | $772.7M |
| Q3 2025 | $793.4M |
| Q4 2025 | $822.6M * |
| Q1 2026 | $850.8M |
| Q2 2026 | $867.0M |
| Q3 2026 | $892.0M |
Data
| Q1 2025 | $3.71 |
| Q2 2025 | $3.92 |
| Q3 2025 | $4.25 |
| Q1 2026 | $5.53 |
| Q2 2026 | $4.69 |
| Q3 2026 | $4.86 |
Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.
Data
| Q4 2024 | 54.5% |
| Q1 2025 | 50.5% |
| Q2 2025 | 55.0% |
| Q3 2025 | 56.4% |
| Q4 2025 | 56.4% |
| Q1 2026 | 53.7% |
| Q2 2026 | 56.2% |
| Q3 2026 | 56.3% |
Data
| Q4 2024 | $416.4M |
| Q1 2025 | $290.1M |
| Q2 2025 | $324.9M |
| Q3 2025 | $445.4M |
| Q4 2025 | $488.7M |
| Q1 2026 | $304.0M |
| Q2 2026 | $359.8M |
| Q3 2026 | $422.7M |
Operating cash flow minus capital expenditure, from cash flow statements.
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $743.5Md | $745.8M | $772.7M | $793.4M | $822.6Md | $850.8M | $867.0M | $892.0M |
| Operating income | $405.2Md | $377.0M | $425.3M | $447.6M | $463.7Md | $456.9M | $487.5M | $502.1M |
| Operating margin | 54.5% | 50.5% | 55.0% | 56.4% | 56.4% | 53.7% | 56.2% | 56.3% |
| Net income | $305.5Md | $288.6M | $303.7M | $325.3M | $284.7Md | $406.0M | $342.0M | $351.0M |
| Diluted EPS | — | $3.71 | $3.92 | $4.25 | — | $5.53 | $4.69 | $4.86 |
| Operating cash flow | $430.6Md | $301.7M | $336.2Md | $449.4Md | $501.1Md | $306.8M | $370.8Md | $436.1Md |
| Capital expenditure | $14.2Md | $11.6M | $11.3Md | $4.0Md | $12.4Md | $2.8M | $11.0Md | $13.4Md |
| Free cash flow | $416.4M | $290.1M | $324.9M | $445.4M | $488.7M | $304.0M | $359.8M | $422.7M |
| R&D expense | $38.5Md | $47.6M | $44.1M | $44.8M | $41.1Md | $49.6M | $46.0M | $47.6M |
From XBRL data in 10-Q and 10-K filings. d derived: a fourth quarter is the full year minus the first nine months, and cash flows are year-to-date figures differenced.
10-K and 10-Q filings
- 20 Oct 202610-Q for the period ended 30 Sep 2026SEC ↗
- 21 Jul 202610-Q for the period ended 30 Jun 2026SEC ↗
- 21 Apr 202610-Q for the period ended 31 Mar 2026SEC ↗
- 6 Feb 202610-K for the period ended 31 Dec 2025SEC ↗
- 28 Oct 202510-Q for the period ended 30 Sep 2025SEC ↗
- 22 Jul 202510-Q for the period ended 30 Jun 2025SEC ↗
- 22 Apr 202510-Q for the period ended 31 Mar 2025SEC ↗
- 7 Feb 202510-K for the period ended 31 Dec 2024SEC ↗